Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00447642 |
|
Recruitment Status :
Terminated
(The primary efficacy endpoint was not met)
First Posted : March 15, 2007
Last Update Posted : October 11, 2012
|
Sponsor:
Lux Biosciences, Inc.
Information provided by (Responsible Party):
Lux Biosciences, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | August 2008 |
| Actual Study Completion Date : | January 2010 |